Nevertheless, given that B-CLL cells exhibit higher ubiquitin-like post-translational modification levels compared to healthy CD19+ B cells [12], their elevated IkBα accumulation is surprising, suggesting alternative regulatory mechanisms. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.